Advisor Group Holdings, Inc. Cardiol Therapeutics Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,014 shares of CRDL stock, worth $4,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,014
Previous 3,827
4.89%
Holding current value
$4,977
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CRDL
# of Institutions
44Shares Held
6.71MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$4.05 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$1.06 Million0.22% of portfolio
-
Lion Street Advisors, LLC340KShares$421,6310.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$363,3890.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$351,5051.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $76.8M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...